Oakworth Capital’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.2K | Hold |
611
| – | – | ﹤0.01% | 375 |
|
|
2025
Q1 | $38.8K | Hold |
611
| – | – | ﹤0.01% | 384 |
|
|
2024
Q4 | $40.6K | Hold |
611
| – | – | ﹤0.01% | 379 |
|
|
2024
Q3 | $42.7K | Hold |
611
| – | – | ﹤0.01% | 372 |
|
|
2024
Q2 | $39.6K | Hold |
611
| – | – | ﹤0.01% | 367 |
|
|
2024
Q1 | $39.5K | Hold |
611
| – | – | ﹤0.01% | 343 |
|
|
2023
Q4 | $40.2K | Hold |
611
| – | – | ﹤0.01% | 347 |
|
|
2023
Q3 | $34.8K | Hold |
611
| – | – | ﹤0.01% | 338 |
|
|
2023
Q2 | $37.4K | Hold |
611
| – | – | ﹤0.01% | 340 |
|
|
2023
Q1 | $38.4K | Hold |
611
| – | – | ﹤0.01% | 326 |
|
|
2022
Q4 | $38.8K | Hold |
611
| – | – | ﹤0.01% | 311 |
|
|
2022
Q3 | $36K | Hold |
611
| – | – | ﹤0.01% | 329 |
|
|
2022
Q2 | $35K | Hold |
611
| – | – | ﹤0.01% | 336 |
|
|
2022
Q1 | $38K | Hold |
611
| – | – | ﹤0.01% | 328 |
|
|
2021
Q4 | $44K | Hold |
611
| – | – | ﹤0.01% | 343 |
|
|
2021
Q3 | $46K | Hold |
611
| – | – | ﹤0.01% | 324 |
|
|
2021
Q2 | $47K | Hold |
611
| – | – | ﹤0.01% | 320 |
|
|
2021
Q1 | $45K | Hold |
611
| – | – | 0.01% | 321 |
|
|
2020
Q4 | $43K | Hold |
611
| – | – | 0.01% | 299 |
|
|
2020
Q3 | $35K | Buy |
+611
| New | +$35K | 0.01% | 322 |
|